Mero-AFT Dosage & Drug Information

Concise Prescribing Info

Contents

Meropenem

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

Adults & childn w/ pneumonias & nosocomial pneumonias; UTI; intra-abdominal, gynaecological (eg, endometritis & pelvic inflammatory disease), skin & skin structure infections; meningitis; septicaemia. Monotherapy or in combination w/ anti-viral or anti-fungal agents as empiric treatment for presumed infections in adult patients w/ febrile neutropenia. Monotherapy or in combination w/ other antimicrobial agents in treatment of polymicrobial infections.

Dosage/Direction for Use

IV Adult Pneumonia, UTI, gynaecological, skin & skin structure infection 500 mg every 8 hr. Nosocomial pneumonia, peritonitis, presumed infection in neutropenic patient, septicaemia 1 g every 8 hr. Meningitis 2 g every 8 hr. Pseudomonas aeruginosa infection 1 g every 8 hr. Max: 6 g daily in 3 divided doses. Adult w/ renal impairment: CrCl 26-50 mL/min 1 unit dose every 12 hr, 10-25 mL/min ½ unit dose every 12 hr, <10 mL/min ½ unit dose every 24 hr. Childn >3 mth to 12 yr 10-20 mg/kg every 8 hr. Childn weighing >50 kg Adult dose. Childn Meningitis 40 mg/kg every 8 hr. Pseudomonas aeruginosa infection 20 mg/kg every 8 hr. Max: 120 mg/kg daily in 3 divided doses.

Contraindications

Hypersensitivity.

MIMS Class

Other Beta-Lactams

ATC Classification

J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the systemic treatment of infections.

Regulatory Classification

POM

Presentation/Packing

Form

Mero-AFT powd for soln for inj 500 mg

Packing/Price

1's

Form

Mero-AFT powd for soln for inj 1 g

Packing/Price

1's

Mero-AFT

meropenem

Manufacturer:

Qilu Antibiotics